(466e) Model-Predictive Control Strategies for Improved Bioprocess Performance
AIChE Annual Meeting
2013
2013 AIChE Annual Meeting
Pharmaceutical Discovery, Development and Manufacturing Forum
Applications of Continuous Processing in the Manufacture of Pharmaceuticals: Drug Substance
Wednesday, November 6, 2013 - 2:10pm to 2:35pm
There is an increase in interest within the biopharmaceutical industry to move from a quality-by-inspection to a quality-by-design (QbD) approach towards process design, optimisation and operation. The implementation of this philosophy through the use of a PAT-enabled control strategy for a bioreactor is decribed in this work. In this study, a number of elements were developed and integrated to implement advanced feedback control of substrate concentrations in a fed-batch CHO cell bioprocess. It is desirable to control substrate and by-product concentrations to provide better process performance in terms of cell density, culture longevity and protein quantity and quality. To implement such control, a Raman spectroscopy method for the simultaneous, real-time measurement of cell density, glucose, glutamine, glutamate, lactate and ammonia was developed. Secondly, a first-principle engineering model of the fed-batch process was identified which facilitated process control simulations. The simulations identified model predictive control (MPC) as a promising form of process control for the inherently complex and highly variable nature of bioprocesses due to its ability to reject measurement noise, handle long sample intervals, cope with non-linear processes and operate as a multiple-input-multiple-output (MIMO) control strategy. Finally, MPC control of glucose and glutamine concentrations was successfully implemented on 3 L and 15 L bioreactors. In transitioning from a bolus to continuous feeding strategy, a 30 % increase in cell density was achieved.